-
Most Popular
Search Results
240 results for bpax
Why Is PaxMedica (PXMD) Stock Up Today?
PXMD stock soared but then retraced most of the price move as today’s traders weighed PaxMedica’s big-money funding agreement.
Kidney Dialysis Stocks are a Profitable Healthcare Bet
This morning, I am recommending a bullish trade on Baxter International Inc. (NYSE:BAX), the renal and hospital product provider.
Quant Score Makes Baxter International (BAX) a Buy
With a $34.6 billion market value, Baxter International Inc (NYSE:BAX) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and…
The Future Keeps Looking Better and Better for BAX Stock
The new Floseal will help Baxter International, but demographics will remain the force that will continue to lift BAX stock.
BAX Stock: Battered Baxter Targeted for Mammoth Upside
BAX stock recently spun off its drugs unit. So can a refocused Baxter, with the help of an activist investor, plot a more profitable future?
Why You Shouldn’t Count Baxter International Inc Stock Out
Baxter International (BAX) stock is still on a roll despite recent turbulence. Here’s what investors should know about the long-term prospects in Baxter stock.
Why Is PaxMedica (PXMD) Stock Up Today?
Although PaxMedica delivered encouraging top-line results for a Phase 3 study, PXMD stock remains a risky investment.
Why Is PaxMedica (PXMD) Stock Up Today?
PaxMedica recently demonstrated encouraging progress with a key therapeutic, but PXMD stock remains highly speculative.
Why Is PaxMedica (PXMD) Stock Down 40% Today?
PXMD stock is sinking lower after the company announced a $7 million public offering of over 5 million shares and warrants.
Is PaxMedica (PXMD) Stock the Next Hot IPO?
PaxMedica has finally gone public. Here’s why this IPO is worth watching and why PXMD stock has room to grow in the future.
Travel Jacket Raises $9 Million on Kickstarter
A new piece of clothing, called the ‘BauBax’ travel jacket, on Kickstarter has reached more than $9 million in funding and has 15 features.
RCAT Stock: 7 Things to Know About the Contract Powering Red Cat Today
U.S. Customs and Border Protection awarded a $90 million contract to Teal Drones, a Red Cat subsidiary. Here’s what to know about RCAT stock.
Trade of the Day: Baxter International Inc (NYSE:BAX)
Despite a frightening landscape, I recommend calls in Baxter International (BAX) since the VIX isn’t pointing to an imminent correction,
Wednesday’s Vital Data: Baxter International Inc (BAX), Delta Air Lines, Inc. (DAL) and Freeport-McMoRan Inc (FCX)
Baxter (BAX) put options pile up as stock breaks down, Delta (DAL) reiterated at “buy” and Freeport-McMoRan (FCX) upgraded to “buy.”
CRWD Stock Alert: CrowdStrike Announces New Partnership With Pax8
CrowdStrike (CRWD) stock is on the move Thursday after announcing a new partnership with cloud commerce marketplace Pax8.
3 Medical Devices Stocks to Sell Now
The overall ratings of three medical devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall…
3 Medical Devices Stocks to Sell Now
The overall ratings of three medical devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall…
3 Medical Devices Stocks to Sell Now
This week, the overall grades of three medical devices stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”)…
3 Medical Devices Stocks to Sell Now
The overall ratings of three medical devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall…
3 Medical Devices Stocks to Sell Now
The ratings of three medical devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
3 Medical Devices Stocks to Sell Now
For the current week, the overall ratings of three medical devices stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D”…
3 Medical Devices Stocks to Sell Now
This week, the overall grades of three medical devices stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”)…
2 – 10 of 240 results